Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBIDS.L Regulatory News (BIDS)

  • There is currently no data for BIDS

Loan Update

30 Apr 2014 12:00

RNS Number : 9054F
Fitbug Holdings PLC
30 April 2014
 



Fitbug Holdings Plc / Epic: FITB.L / Index: AIM / Sector: Leisure

30 April 2014

Fitbug Holdings Plc ('Fitbug' or 'the Company')

Agrees extension of all loans to mid 2015 and secures additional £1 million loan on attractive terms

Legal action against Fitbit on course for court decision in 2015.

 

Fitbug Holdings Plc, the AIM listed provider of online personal health and well-being services, is pleased to announce that it has agreed that the repayment date of all loans to the Company from NW1 Investments Limited and Kifin Limited, a Kirsh Group subsidiary, be extended to 31 July 2015. Other terms remain unchanged including the interest rate which remains at 5%.

 

The Company is also pleased to announce that it has agreed a further £1 million loan ('the Loan') from NW1 Investments Limited ('Loan Holder'). The Loan is repayable by 31 July 2015 and will accrue interest at 5% per annum, payable on a quarterly basis. NW1 Investments Limited is a company in which the family of David Turner and Allan Fisher, both directors of Fitbug, have a material interest.

 

The independent directors of the Company, being Fergus Kee, Malcolm Fried, Paul Landau, Ann Jones, Geoffrey Simmonds and Andrew Brummer, consider, having consulted with Cantor Fitzgerald Europe, that the terms of the Loan are fair and reasonable in so far as shareholders are concerned.

 

The Company's legal action against Fitbit alleging trademark infringement, as well as unfair competition and unfair business practices, continues to progress and is scheduled to go to trial in the U.S. District Court for the Northern California in early 2015.

 

Fergus Kee, Chairman of Fitbug said, "This term extension on existing loans and the additional loan capital, both on attractive terms, significantly strengthens the Company's financial position at a time of strongly growing demand for wearable technology. We have an exciting pipeline of business ahead and we look forward to developing this and continuing our investment into both our sales strategy and product."

 

**ENDS**

 

For further information contact:

 

Paul Landau/Andrew Brummer

Fitbug Holdings Plc

020 7449 1000

Mark Percy/Catherine Leftley

Cantor Fitzgerald Europe

020 7894 7000

Claire Louise Noyce / William Lynne

Hybridan LLP

020 7947 4350 / 020 7947 4361

Elisabeth Cowell/Charlotte Heap

St Brides Media & Finance Ltd

020 7236 1177

 

 

Notes

 

Fitbug is a leading provider of online health and well-being services to help individuals to improve their lifestyles by making realistic changes to their daily routine. It combines activity tracking devices, which download to the Fitbug app and fitbug.com to provide an understanding of each user's daily activity achievements, with mobile and web technology providing users with personalised weekly activity and nutrition targets, feedback, advice and encouragement.

 

Key market sectors and distribution channels include retail, health insurance and rewards providers, workplace health programmes fitness operators and consumers. Increasingly, Fitbug's platform acts as the driving force behind third party services such as white label sites, activity driven games and challenge microsites and rewards programmes. The Company's main focus is now on building strategic partnerships with organisations that can integrate Fitbug into their own service/product offerings or resell to their customer base. The Company has operations in the UK, Australia and Asia, with the United States remaining the primary market. For more information, visit www.fitbug.com.

 

The Fitbug business was founded by Paul Landau, CEO of Fitbug Limited. Fergus Kee, Chairman of the Company is the former Managing Director of Bupa's £2.1 billion turnover UK and North American Division.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCIMMMTMBMJBFI
Date   Source Headline
11th Feb 20202:06 pmRNSSecond Price Monitoring Extn
11th Feb 20202:00 pmRNSPrice Monitoring Extension
11th Feb 202011:05 amRNSSecond Price Monitoring Extn
11th Feb 202011:00 amRNSPrice Monitoring Extension
11th Feb 20207:15 amRNSAppointment of Andrew House to Advisory Committee
11th Feb 20207:00 amRNS2019 Year End Trading Update
10th Feb 20202:06 pmRNSSecond Price Monitoring Extn
10th Feb 20202:00 pmRNSPrice Monitoring Extension
3rd Jan 20204:40 pmRNSSecond Price Monitoring Extn
3rd Jan 20204:35 pmRNSPrice Monitoring Extension
23rd Dec 20199:35 amRNSBlock listing Interim Review
20th Dec 20196:06 pmRNSConfirmation regarding Trading Update
19th Dec 20197:00 amRNSMilestone Advertising Trading Agreement
18th Dec 20197:00 amRNSTrading Update
17th Dec 20192:06 pmRNSSecond Price Monitoring Extn
17th Dec 20192:00 pmRNSPrice Monitoring Extension
4th Nov 201910:17 amRNSGrant of Share Options
29th Oct 201911:34 amRNSAppointment of Bryan Neider to Advisory Committee
28th Oct 20193:21 pmRNSExercise of Options and Total Voting Rights
28th Oct 201911:05 amRNSSecond Price Monitoring Extn
28th Oct 201911:00 amRNSPrice Monitoring Extension
28th Oct 201910:25 amRNSDirectors' dealings
30th Sep 20197:00 amRNSInterim results for the six months ended 30 June
27th Sep 20195:24 pmRNSStrategic Partnership with Dentsu Aegis Network
26th Sep 20197:00 amRNSExtension of Football Manager Agreement
17th Sep 201912:13 pmRNSNotice of Results
30th Aug 201911:03 amRNSTotal Voting Rights
29th Aug 20194:01 pmRNSNew contract with The Trade Desk
22nd Aug 20192:35 pmRNSChange of Broker
19th Aug 201911:45 amRNSCollaboration with Epic Games' Unreal Engine
13th Aug 20192:06 pmRNSSecond Price Monitoring Extn
13th Aug 20192:00 pmRNSPrice Monitoring Extension
12th Aug 20195:09 pmRNSBidstack signs contract with AppNexus
1st Aug 20197:00 amRNSAcquisition of Pubguard
31st Jul 20197:00 amRNSTotal Voting Rights
11th Jul 20194:40 pmRNSSecond Price Monitoring Extn
11th Jul 20194:35 pmRNSPrice Monitoring Extension
11th Jul 20192:05 pmRNSSecond Price Monitoring Extn
11th Jul 20192:00 pmRNSPrice Monitoring Extension
2nd Jul 20197:00 amRNSAppointment of Derek Wise and other Board changes
24th Jun 20193:42 pmRNSResults of Independent Study by Lumen Research
11th Jun 20198:09 amRNSBlock Listing Application
11th Jun 20197:00 amRNSExercise of Warrants and Total Voting Rights
7th Jun 20197:00 amRNSIssue of Equity and Total Voting Rights
6th Jun 201910:01 amRNSExercise of Warrants and Total Voting Rights
6th Jun 20197:00 amRNSExercise of Warrants and Total Voting Rights
3rd Jun 20197:00 amRNSExercise of Warrants and Total Voting Rights
31st May 20195:04 pmRNSAppointments to Advisory Board
28th May 20199:05 amRNSSecond Price Monitoring Extn
28th May 20199:00 amRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.